56.12
price down icon2.14%   -1.23
after-market Handel nachbörslich: 56.22 0.10 +0.18%
loading

Gsk Plc Adr Aktie (GSK) Neueste Nachrichten

pulisher
Apr 19, 2026

GSK plc (ADR) stock (GB0009252882): Why Google Discover changes matter more now - AD HOC NEWS

Apr 19, 2026
pulisher
Apr 17, 2026

GSK Forecast, Price Target & Analyst Ratings | GSK PLC-SPON ADR (NYSE:GSK) - ChartMill

Apr 17, 2026
pulisher
Apr 16, 2026

GSK PLC Sponsored ADR (NYSE:GSK) Sees Significant Growth in Short Interest - MarketBeat

Apr 16, 2026
pulisher
Apr 14, 2026

GSK plc (ADR) stock (GB0009252882): Why its vaccines and specialty medicines strategy is suddenly wo - AD HOC NEWS

Apr 14, 2026
pulisher
Apr 13, 2026

GSK Stock Chart | GSK PLC-SPON ADR (NYSE:GSK) - ChartMill

Apr 13, 2026
pulisher
Apr 10, 2026

7MM Systemic Lupus Erythematosus and Lupus Nephritis Drug Market Analysis & Forecast 2024-2034: Future SLE and LN Players Competition, High Unmet Need for Steroid-sparing Treatments - GlobeNewswire Inc.

Apr 10, 2026
pulisher
Apr 10, 2026

Douglas Lane & Associates LLC Cuts Holdings in GSK PLC Sponsored ADR $GSK - MarketBeat

Apr 10, 2026
pulisher
Apr 07, 2026

GSK plc (GSK) stock price, news, quote and history - Yahoo Finance Singapore

Apr 07, 2026
pulisher
Apr 03, 2026

GSK plc (GSK) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 03, 2026
pulisher
Apr 02, 2026

GSK plc (ADR) Stock: ViiV Healthcare Ownership Restructured as Pfizer Exits, Strengthening GSK's HIV - AD HOC NEWS

Apr 02, 2026
pulisher
Apr 02, 2026

GSK PLC Sponsored ADR (NYSE:GSK) Receives Average Recommendation of "Reduce" from Analysts - MarketBeat

Apr 02, 2026
pulisher
Mar 31, 2026

GSK Stock Price, Quote & Chart | GSK PLC-SPON ADR (NYSE:GSK) - ChartMill

Mar 31, 2026
pulisher
Mar 26, 2026

GSK Fundamental Analysis & Valuation | Fair Value & Financial Strength | GSK PLC-SPON ADR (NYSE:GSK) - ChartMill

Mar 26, 2026
pulisher
Mar 21, 2026

GSK plc (ADR) stock surges on FDA approval for Lynavoy as pipeline momentum builds for 2026 - AD HOC NEWS

Mar 21, 2026
pulisher
Mar 18, 2026

GSK's Q4 earnings & sales beat estimates, stock up on '26 outlook - MSN

Mar 18, 2026
pulisher
Mar 16, 2026

GSK PLC Sponsored ADR (NYSE:GSK) Short Interest Update - MarketBeat

Mar 16, 2026
pulisher
Mar 14, 2026

FDA Broadens Access To GSK's Respiratory Syncytial Virus Shot For Younger High-Risk Adults - Sahm

Mar 14, 2026
pulisher
Mar 10, 2026

GSK Out-Licenses Rights for Rare Liver Disease Drug to Alfasigma - Finviz

Mar 10, 2026
pulisher
Mar 07, 2026

GSK PLC Sponsored ADR $GSK Shares Sold by Quantbot Technologies LP - MarketBeat

Mar 07, 2026
pulisher
Mar 06, 2026

GSK (NYSE: GSK) files 2025 Form 20-F with audited 2025 financial statements - Stock Titan

Mar 06, 2026
pulisher
Mar 04, 2026

Price Over Earnings Overview: GSK - Sahm

Mar 04, 2026
pulisher
Mar 03, 2026

GlaxoSmithKline Pharma: Can India’s GSK Arm Still Reward US Investors? - AD HOC NEWS

Mar 03, 2026
pulisher
Mar 03, 2026

GSK PLC Sponsored ADR $GSK Shares Sold by Kahn Brothers Group Inc. - MarketBeat

Mar 03, 2026
pulisher
Mar 02, 2026

GSK PLC Sponsored ADR (NYSE:GSK) Short Interest Down 26.3% in February - MarketBeat

Mar 02, 2026
pulisher
Mar 02, 2026

CapEx per share of GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs – BCBA:GSKD - TradingView

Mar 02, 2026
pulisher
Mar 02, 2026

Fisher Asset Management LLC Purchases 889,210 Shares of GSK PLC Sponsored ADR $GSK - MarketBeat

Mar 02, 2026
pulisher
Mar 02, 2026

Antibiotics Market - GlobeNewswire Inc.

Mar 02, 2026
pulisher
Feb 25, 2026

GSK Expands Pipeline With $950 Million Pulmonary Hypertension Power Play - Sahm

Feb 25, 2026
pulisher
Feb 24, 2026

SMMT Incurs Wider-Than-Expected Q4 Loss, Pipeline Progress in Focus - Finviz

Feb 24, 2026
pulisher
Feb 24, 2026

GSK (GSK) Announces 75.6% Vaccine Effectiveness for Arexvy in Real-World RSV Study - Finviz

Feb 24, 2026
pulisher
Feb 19, 2026

Moderna Stock Jumps After FDA Reverses Course on Flu Shot - TradingView

Feb 19, 2026
pulisher
Feb 17, 2026

GlaxoSmithKline Pharma: Quiet India Move, Big Signal for U.S. Portfolios? - AD HOC NEWS

Feb 17, 2026
pulisher
Feb 15, 2026

GSK plc (GSK) Q4 Results Topped Forecasts as Specialty Medicines Jump 17% - Finviz

Feb 15, 2026
pulisher
Feb 13, 2026

Best International Companies to Own: 2026 Edition - Morningstar

Feb 13, 2026
PFE PFE
$27.31
price down icon 0.76%
$133.29
price down icon 1.90%
NVO NVO
$39.42
price down icon 2.57%
$344.86
price down icon 1.51%
MRK MRK
$112.56
price down icon 3.88%
NVS NVS
$147.97
price down icon 2.00%
Kapitalisierung:     |  Volumen (24h):